Anti-angiogenic collagen IV-derived peptide target engagement with αvβ3 and α5β1 in ocular neovascularization models
Raquel Lima e Silva(Johns Hopkins Medicine), Peter A. Campochiaro(Johns Hopkins University)
Cited by 12
Related Papers
VEGF/VEGFR2 blockade does not cause retinal atrophy in AMD-relevant models
|JCI Insight|2018|27